Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

My Pathway: A Study Evaluating Herceptin / Perjeta, Tarceva, Zelboraf / Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors


This multicenter, non-randomized, open-label study will evaluate the efficacy and safety of six treatment regimens in participants with advanced solid tumors for whom therapies that will convey clinical benefit are not available and / or are not suitable options per the treating physician's judgment.
Davis, Elizabeth

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: